Selected coagulation disorders associated with cancer

Area of Science:

• Oncology
• Hematology
• Medical Research

Background:

• Established link between cancer and heightened risks of bleeding and thrombosis.
• Tumor-related and plasma factors implicated in cancer-associated hemostatic dysregulation.
• Mechanisms underlying these hemostatic complications in cancer remain under investigation.

Purpose of the Study:

• To provide a comprehensive overview of significant hemostatic challenges faced by cancer patients.
• To highlight the importance of understanding malignancy progression and treatment effects on hemostasis.
• To aid clinicians in diagnosing and managing bleeding and clotting disorders in oncology.

Main Methods:

• Literature review of studies on cancer and hemostasis.
• Analysis of tumor- and plasma-related factors influencing hemostatic balance.
• Discussion of clinical diagnostic considerations for oncologic hemostatic emergencies.

Main Results:

• Cancer patients exhibit a well-documented predisposition to both bleeding and thrombotic events.
• Multiple interacting factors, originating from both the tumor and the host plasma, contribute to this risk.
• The exact contribution of individual factors to specific hemostatic complications is often speculative.

Conclusions:

• Effective management requires understanding the underlying malignancy, treatment modalities, and clinical presentation.
• A high index of clinical suspicion is essential for prompt diagnosis of hemostatic issues in cancer.
• This overview aims to equip physicians with knowledge of key hemostatic problems in cancer care.